BP p.l.c. posted a 5.2% single-day gain on Tuesday and closed the week up 2.4% at 540p — a welcome recovery after a rough August that left the stock down 2% on the month.
The bounce puts BP roughly in line with the broader energy complex. Closest peer SHEL added 1% on the week, while TTE rose 2.1% and EQNR gained 2.7%. REP was the standout, up 3.3%. BP's daily move of 5.2% was the biggest in the group, suggesting Tuesday's push came with some force — though it still doesn't fully close the gap to peers that have held up better through the year.
The lending market is essentially irrelevant here. Availability is at maximum — over 15 billion shares sitting idle in the lending pool — and cost to borrow has eased 15% over the past week to a negligible 0.58%. The short score reads 25.3 and has barely moved in a fortnight. This is not a stock bears are pressing. The ORTEX factor score confirms it: BP ranks in the 95th percentile on short score, meaning shorts are about as absent as they can be in this name.
Where the picture gets more interesting is on quality and valuation. The ORTEX stock score leans heavily on BP's fundamentals. A perfect Piotroski F-score of 9, a return on assets of 5.38%, and a price-to-book of 1.74 that has actually drifted lower over the past month — these point to a company that screens well on value and balance sheet discipline. The EV/EBITDA has also eased to 3.9, compressing slightly over 30 days. The dividend yield factor scores in the 97th percentile, and with the most recent quarterly payout at £0.062, income investors have a concrete reason to stay engaged. The EP ratio — earnings divided by price — has moved higher over the past week, reflecting either the price dip or improving earnings estimates.
The institutional register adds texture. BlackRock holds 9.2% and added 13 million shares in the most recent period. GQG Partners is the more aggressive mover: the firm added 77.6 million shares to bring its stake to 2.3% of the company — a meaningful build from an active manager. HSBC Global Asset Management and Rabobank also added significantly. That's a cluster of buyers at a time when the stock has been soft, which is at least consistent with a value-driven accumulation thesis.
Insider activity is less clean. The most recent significant open-market trades were sells: Deputy CEO Carol-Lee Howle disposed of 350,000 shares in May at 559p, and two other EVP-level executives sold in March. The 90-day net figure is technically positive at 678,847 shares, but that's dominated by award grants, not open-market conviction buys. Strips those out and the directional read from insiders is mildly negative.
Q2 earnings, reported on 4 August, delivered a 15% year-on-year rise in adjusted profit on stronger refining margins and upstream volumes — but the stock fell 6.7% on the day and remained under water five days later. The pattern repeated from Q1: a modest gain on the print in April, followed by a five-day drift lower. Markets are apparently looking past headline beats and focusing on something else — whether that is strategic clarity, capital allocation priorities, or the macro crude outlook.
The next quarterly print lands 30 October. Between now and then, the setup to watch is whether GQG's sizeable build and BlackRock's incremental additions translate into a stickier floor around current levels — or whether the stock fades again as the earnings enthusiasm from Tuesday's bounce dissipates.
See the live data behind this article on ORTEX.
Open BP. on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
